Reverse iontophoresis as a noninvasive tool for lithium monitoring and pharmacokinetic profiling

Pharmaceutical Research

Volumn 21, Issue 7, 2004, Pages 1214-1222

  Leboulanger, Benoît ^a   Fathi, Marc ^b   Guy, Richard H ^a   Delgado Charro, M Begoña ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

iontophoresis; lithium; reverse iontophoresis; therapeutic drug monitoring; transdermal extraction.

Indexed keywords

BUFFER; LITHIUM CHLORIDE; POTASSIUM; SODIUM;

ANIMAL TISSUE; ARTICLE; CALIBRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DERMATOME; DERMIS; DRUG ELIMINATION; DRUG MONITORING; EAR; ELECTRICITY; ELECTRODE; EXTRACTION; IN VITRO STUDY; IONTOPHORESIS; NONHUMAN; PRIORITY JOURNAL; SIMULATION; SWINE;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG MONITORING; EAR; IONTOPHORESIS; LITHIUM COMPOUNDS; MODELS, BIOLOGICAL; SKIN ABSORPTION; SWINE; TIME FACTORS;

EID: 3242733188     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000033008.64915.c8     Document Type: Article

References (30)

1. B. Bailey, J. Klein, and G. Koren. Noninvasive methods for drug measurement in pediatrics. Pediatr. Clin. North Am. 44:15-26 (1997).
2. L. J. Rice. Needle phobia. An anesthesiologist's perspective. J. Peadiatr. 122:S9-S13 (1993).
3. A. Amdisen. Serum concentration and clinical supervision in monitoring of lithium treatment. Ther. Drug Monit. 2:73-83 (1980).
4. A. Amdisen. Serum level monitoring and clinical pharmacokinetics of lithium. Clin. Pharmacokinet. 2:73-92 (1977).
5. R. F. Kehoe. Monitoring lithium treatment. BMJ 306:269-270 (1993).
6. M. Schou. Lithium treatment during pregnancy, delivery, and lactation: an update. J. Clin. Psychiatry 51:410-413 (1990).
7. S. Pichini, I. Altieri, P. Zuccaro, and R. Pacifici. Drug monitoring in nonconventional biological fluids and matrices. Clin. Pharmacokinet. 30:211-228 (1996).
8. J. P. Moody. Biologic variation of serum and salivary lithium. Ther. Drug Monit. 21:97-101 (1999).
9. R. Obach, J. Borja, J. Prunonosa, J. M. Valles, J. Torrent, I. Izquierdo, and F. Jane. Lack of correlation between lithium pharmacokinetic parameters obtained from plasma and saliva. Ther. Drug Monit. 10:265-268 (1988).
10. M. B. Delgado-Charro and R. H. Guy. Transdermal reverse iontophoresis of valproate: a non-invasive method for therapeutic drug monitoring. Pharm. Res. 20:1508-1513 (2003).
11. B. Leboulanger, R. H. Guy, and M. B. Delgado-Charro. Reverse iontophoretic monitoring of free phenytoin. Ther. Drug Monit. 25:499 (2003).
12. V. Merino, A. Lopez, D. Hochstrasser, and R. H. Guy. Noninvasive sampling of phenylalanine by reverse iontophoresis. J. Control. Rel. 61:65-69 (1999).
13. G. Rao, P. Glikfeld, and R. H. Guy. Reverse iontophoresis: development of a non invasive approach for glucose monitoring. Pharm. Res. 10:1751-1755 (1993).
14. J. A. Tamada, N. J. V. Bohannon, and R. O. Potts. Measurement of glucose in diabetic subjects using noninvasive transdermal extraction. Nat. Med. 1:1198-1201 (1995).
15. M. J. Tierney, J. A. Tamada, R. O. Potts, R. C. Eastman, K. Pitzer, N. R. Ackerman, and S. J. Fermi. The GlucoWatch® biographer: a frequent automatic and noninvasive glucose monitor. Ann. Med. 32:632-641 (2000).
16. R. R. Burnette. Iontophoresis. In J. Hadgraft and R. H. Guy (eds.), Transdermal Drug Delivery, Marcel Dekker, New York, 1989, pp. 247-291.
17. P. W. Ledger. Skin biological issues in electrically enhanced transdermal delivery. Adv. Drug Deliv. Rev. 9:289-307 (1992).
18. J. B. Phipps and J. R. Gyory. Transdermal ion migration. Adv. Drug Deliv. Rev. 9:137-176 (1992).
19. M. J. Pikal. The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug Deliv. Rev. 9:201-237 (1992).
20. B. Leboulanger and R. H. Guy. and M. B. Delgado-Charro Reverse iontophoresis for non-invasive transdermal monitoring. Physiol. Meas. 25:R35-R50 (2003).
21. D. Marro, Y. N. Kalia, M. B. Delgado-Charro, and R. H. Guy. Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm. Res. 18:1701-1708 (2001).
22. R. R. Burnette and B. Ongpipattanakul. Characterization of the permselective properties of excised human skin during iontophoresis. J. Pharm. Sci. 76:765-773 (1987).
23. R. O. Potts, J. A. Tamada, and M. J. Tierney. Glucose monitoring by reverse iontophoresis. Diabetes Metab. Res. Rev. 18:S49-S53 (2002).
24. A. Sieg, R. H. Guy, and M. B. Delgado-Charro. Reverse iontophoresis for non-invasive glucose monitoring: the internal standard concept. J. Pharm. Sci. 92:2295-2302 (2003).
25. P. Glikfeld, C. Cullander, R. S. Hinz, and R. H. Guy. A new system for in vitro studies of iontophoresis. Pharm. Res. 5:443-446 (1988).
26. P. G. Green, R. S. Hinz, C. Cullander, G. Yamane, and R. H. Guy. Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro. Pharm. Res. 8:1113-1120 (1991).
27. G. Houin. Pharmacocinétique, Edition Marketing, Paris, France, 1990.
28. R. J. Flanagan. Guidelines for the interpretation of analytical toxicology results and unit of measurement conversion factors. Ann. Clin. Biochem. 35:261-267 (1998).
29. M. E. Winter, Lithium. In M. E. Winter (ed), Basic clinical pharmacokinetics, Applied Therapeutics, Vancouver, WA, USA, 1994, pp. 257-265.
30. M. E. Winter. Basic Clinical Pharmacokinetics, Applied Therapeutics, Vancouver, WA, USA, 1994.